Hirokuni Kitamei

870 total citations
19 papers, 448 citations indexed

About

Hirokuni Kitamei is a scholar working on Ophthalmology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hirokuni Kitamei has authored 19 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Ophthalmology, 4 papers in Rheumatology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hirokuni Kitamei's work include Ocular Diseases and Behçet’s Syndrome (9 papers), Retinal Diseases and Treatments (8 papers) and Retinal and Optic Conditions (5 papers). Hirokuni Kitamei is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (9 papers), Retinal Diseases and Treatments (8 papers) and Retinal and Optic Conditions (5 papers). Hirokuni Kitamei collaborates with scholars based in Japan, United States and Spain. Hirokuni Kitamei's co-authors include Shigeaki Ohno, Mizuki Kitamura, Kenichi Namba, Taiichi Hikichi, Nobuyoshi Kitaichi, Kimitaka Takami, Kazuhiko Yoshida, Satoshi Kotake, Kazunori Onoé and Kazuya Iwabuchi and has published in prestigious journals such as The Journal of Immunology, American Journal of Ophthalmology and Journal of Leukocyte Biology.

In The Last Decade

Hirokuni Kitamei

19 papers receiving 429 citations

Peers

Hirokuni Kitamei
Hirokuni Kitamei
Citations per year, relative to Hirokuni Kitamei Hirokuni Kitamei (= 1×) peers Yuko Takemoto

Countries citing papers authored by Hirokuni Kitamei

Since Specialization
Citations

This map shows the geographic impact of Hirokuni Kitamei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokuni Kitamei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokuni Kitamei more than expected).

Fields of papers citing papers by Hirokuni Kitamei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirokuni Kitamei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokuni Kitamei. The network helps show where Hirokuni Kitamei may publish in the future.

Co-authorship network of co-authors of Hirokuni Kitamei

This figure shows the co-authorship network connecting the top 25 collaborators of Hirokuni Kitamei. A scholar is included among the top collaborators of Hirokuni Kitamei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirokuni Kitamei. Hirokuni Kitamei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Satoh, Masashi, Nobuyoshi Kitaichi, Noriko Endo, et al.. (2016). Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis. Experimental Eye Research. 153. 79–89. 9 indexed citations
2.
Hikichi, Taiichi, et al.. (2016). Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy. BMC Ophthalmology. 16(1). 6 indexed citations
3.
Hikichi, Taiichi, et al.. (2014). Intraoperative endoscopic observation of sclerotomy site after cannula removal for 23-gauge vitrectomy. Clinical ophthalmology. 8. 477–477. 3 indexed citations
4.
Hikichi, Taiichi, Hirokuni Kitamei, Makoto Higuchi, et al.. (2014). Relation between changes in foveal choroidal thickness and 1-year results of ranibizumab therapy for polypoidal choroidal vasculopathy. British Journal of Ophthalmology. 98(9). 1201–1204. 18 indexed citations
5.
Hikichi, Taiichi, et al.. (2014). Prognostic factors of 2-year outcomes of ranibizumab therapy for polypoidal choroidal vasculopathy. British Journal of Ophthalmology. 99(6). 817–822. 18 indexed citations
6.
Hikichi, Taiichi, Makoto Higuchi, Takuro Matsushita, et al.. (2013). Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy. British Journal of Ophthalmology. 97(5). 617–621. 41 indexed citations
7.
Hikichi, Taiichi, Makoto Higuchi, Takuro Matsushita, et al.. (2013). Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion. British Journal of Ophthalmology. 98(2). 195–199. 38 indexed citations
8.
Saito, Wataru, et al.. (2012). Photodynamic therapy combined with intravitreal bevacizumab and sub-tenon triamcinolone acetonide injections for age-related macular degeneration. Japanese Journal of Ophthalmology. 57(1). 68–73. 10 indexed citations
9.
Kitamei, Hirokuni, et al.. (2012). Chickenpox Chorioretinitis with Retinal Exudates and Periphlebitis. Case Reports in Ophthalmology. 3(2). 180–184. 3 indexed citations
10.
Kitamei, Hirokuni, Yasuo Suzuki, Mitsuo Takahashi, et al.. (2009). Retinal Angiography and Optical Coherence Tomography Disclose Focal Optic Disc Vascular Leakage and Lipid-Rich Fluid Accumulation Within the Retina in a Patient With Leber Idiopathic Stellate Neuroretinitis. Journal of Neuro-Ophthalmology. 29(3). 203–207. 13 indexed citations
11.
Iwata, Daiju, Mizuki Kitamura, Nobuyoshi Kitaichi, et al.. (2009). Prevention of experimental autoimmune uveoretinitis by blockade of osteopontin with small interfering RNA. Experimental Eye Research. 90(1). 41–48. 16 indexed citations
12.
Kitamei, Hirokuni, Nobuyoshi Kitaichi, Kenichi Namba, et al.. (2008). Clinical features of intraocular inflammation in Hokkaido, Japan. Acta Ophthalmologica. 87(4). 424–428. 61 indexed citations
13.
Kitamura, Mizuki, Kazuya Iwabuchi, Nobuyoshi Kitaichi, et al.. (2007). Osteopontin Aggravates Experimental Autoimmune Uveoretinitis in Mice. The Journal of Immunology. 178(10). 6567–6572. 29 indexed citations
14.
Namba, Kenichi, Koh‐Hei Sonoda, Hirokuni Kitamei, et al.. (2006). Granulocytapheresis in patients with refractory ocular Behcet's disease. Journal of Clinical Apheresis. 21(2). 121–128. 18 indexed citations
15.
Kitamei, Hirokuni, Nobuyoshi Kitaichi, Kazuhiko Yoshida, et al.. (2006). Association of heat shock protein 70 induction and the amelioration of experimental autoimmune uveoretinitis in mice. Immunobiology. 212(1). 11–18. 14 indexed citations
16.
Kitamei, Hirokuni, Kazuya Iwabuchi, Kenichi Namba, et al.. (2006). Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-κB (NF-κB), pyrrolidine dithiocarbamate. Journal of Leukocyte Biology. 79(6). 1193–1201. 39 indexed citations
17.
Kitamura, Mizuki, et al.. (2005). Comparative Study of Two Sets of Criteria for the Diagnosis of Vogt-Koyanagi-Harada’s Disease. American Journal of Ophthalmology. 139(6). 1080–1085. 39 indexed citations
18.
Kitamei, Hirokuni, Masahiko Yokoi, Manabu Kase, & Shigeaki Ohno. (2005). Retinal neovascularization during treatment with IGF-1 for insulin resistance syndrome. Graefe s Archive for Clinical and Experimental Ophthalmology. 243(7). 715–717. 7 indexed citations
19.
Ilieva, Iliyana, Kazuhiro Ohgami, Kenji Shiratori, et al.. (2004). The effects of Ginkgo biloba extract on lipopolysaccharide-induced inflammation in vitro and in vivo. Experimental Eye Research. 79(2). 181–187. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026